Truist Securities Reiterates Hold on Medtronic, Raises Price Target to $99

Benzinga Newsdesk www.benzinga.com Positive 66.1%

Neg 0% Neu 0% Pos 66.1%

Truist Securities analyst Richard Newitter reiterates Medtronic (NYSE:MDT) with a Hold and raises the price target from $86 to $99.